Correlation Between Regeneron Pharmaceuticals and CSL
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and CSL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and CSL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and CSL Limited, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and CSL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of CSL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and CSL.
Diversification Opportunities for Regeneron Pharmaceuticals and CSL
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Regeneron and CSL is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and CSL Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CSL Limited and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with CSL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CSL Limited has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and CSL go up and down completely randomly.
Pair Corralation between Regeneron Pharmaceuticals and CSL
Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to generate 0.52 times more return on investment than CSL. However, Regeneron Pharmaceuticals is 1.93 times less risky than CSL. It trades about -0.02 of its potential returns per unit of risk. CSL Limited is currently generating about -0.03 per unit of risk. If you would invest 70,095 in Regeneron Pharmaceuticals on December 20, 2024 and sell it today you would lose (2,859) from holding Regeneron Pharmaceuticals or give up 4.08% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 93.33% |
Values | Daily Returns |
Regeneron Pharmaceuticals vs. CSL Limited
Performance |
Timeline |
Regeneron Pharmaceuticals |
CSL Limited |
Regeneron Pharmaceuticals and CSL Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Regeneron Pharmaceuticals and CSL
The main advantage of trading using opposite Regeneron Pharmaceuticals and CSL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, CSL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CSL will offset losses from the drop in CSL's long position.Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
CSL vs. Pmv Pharmaceuticals | CSL vs. Novo Nordisk AS | CSL vs. Kalvista Pharmaceuticals | CSL vs. ProKidney Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |